Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects

By Fahrmayr Christina   Fromm Martin F.   König Jörg  

Drug Metabolism Reviews, Vol. 42, Iss. 3, 2010-08 ,pp. : 380-401

Informa Healthcare

Access to resources Recommend Favorite

Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions

By Kis Olena   Zastre Jason   Hoque Md.   Walmsley Sharon   Bendayan Reina  

Pharmaceutical Research, Vol. 30, Iss. 4, 2013-04 ,pp. : 1050-1064

Springer Publishing Company

Access to resources Recommend Favorite

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

By Kostapanos Michael S.   Milionis Haralampos J.   Elisaf Moses S.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 11-28

Adis International

Access to resources Recommend Favorite

Is pomegranate juice a potential perpetrator of clinical drug–drug interactions? Review of the in vitro, preclinical and clinical evidence

By Srinivas Nuggehally  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 38, Iss. 4, 2013-12 ,pp. : 223-229

Springer Publishing Company

Access to resources Recommend Favorite

Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation

By  

Current Drug Metabolism, Vol. 17, Iss. 5, 2016-06 ,pp. : 456-468

Bentham Science Publishers

Access to resources Recommend Favorite